A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics

Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype

(2014) Yi Zhang et al.   PSYCHOPHARMACOLOGY

Favorable Effect of Short-Term Lifestyle Intervention on Human Paraoxonase-1 Activity and Adipokine Levels in Childhood Obesity

(2013) Péter Koncsos et al.   JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION

Health Effects of Mixed Fruit and Vegetable Concentrates: A Systematic Review of the Clinical Interventions

(2013) Amin Esfahani et al.   JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

(2012) Benjamin F Voight et al.   LANCET

Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia

(2011) Xiang Yang Zhang et al.   NEUROPHARMACOLOGY

The three-gene paraoxonase family: Physiologic roles, actions and regulation

(2010) Louis-Philippe Précourt et al.   ATHEROSCLEROSIS

Clozapine Treatment Causes Oxidation of Proteins Involved in Energy Metabolism in Lymphoblastoid Cells: A Possible Mechanism for Antipsychotic- Induced Metabolic Alterations

(2010) Muhammad R. Baig et al.   Journal of Psychiatric Practice

Obesity Among Those with Mental Disorders

(2009) David B. Allison et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Pharmacological Management of Atypical Antipsychotic-Induced Weight Gain

(2009) Trino Baptista et al.   CNS DRUGS

The relationships of leptin, adiponectin levels and paraoxonase activity with metabolic and cardiovascular risk factors in females treated with psychiatric drugs

(2008) Aliye Ozenoglu et al.   Clinics

Clozapine causes oxidation of proteins involved in energy metabolism: a possible mechanism for antipsychotic-induced metabolic alterations

(2008) Consuelo Walss-Bass et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY